Opioid Prescription Denials by Community Pharmacies for Cancer-Related Pain: A Case Series

J Pain Symptom Manage. 2023 Sep;66(3):e431-e435. doi: 10.1016/j.jpainsymman.2023.06.027. Epub 2023 Jun 24.

Abstract

Pain is one of the most common symptoms experienced by patients living with cancer. Guidelines recommend opioids as the mainstay in the management of cancer-related pain. However, the opioid epidemic has resulted in policymakers recommending limitations on opioid prescribing which led to community pharmacies implementing various parameters. These restrictions have created barriers for patients with cancer-related pain attempting to fill opioid prescriptions from their community pharmacies. Additionally, in the setting of the opioid epidemic, there have been reports of systemic bias within community pharmacies, leading to experiences with embarrassment and shame for patients with cancer-related pain. This case series presents specific examples of community pharmacies declining to fill opioid prescriptions for patients with cancer-related pain and associated patient suffering.

MeSH terms

  • Adult
  • Analgesics, Opioid* / administration & dosage
  • Analgesics, Opioid* / therapeutic use
  • Bias
  • Cancer Pain* / drug therapy
  • Cancer Pain* / psychology
  • Drug Prescriptions* / standards
  • Drug Prescriptions* / statistics & numerical data
  • Embarrassment
  • Female
  • Humans
  • Male
  • Middle Aged
  • Opioid Epidemic / prevention & control
  • Pain
  • Pharmacies*
  • Pharmacists
  • Pharmacy* / methods
  • Shame

Substances

  • Analgesics, Opioid